These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20091489)

  • 41. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
    Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
    Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitation of saccharide compositions of O-glycans by mass spectrometry of glycopeptides and its application to rheumatoid arthritis.
    Wada Y; Tajiri M; Ohshima S
    J Proteome Res; 2010 Mar; 9(3):1367-73. PubMed ID: 20104905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
    Takahashi K; Wall SB; Suzuki H; Smith AD; Hall S; Poulsen K; Kilian M; Mobley JA; Julian BA; Mestecky J; Novak J; Renfrow MB
    Mol Cell Proteomics; 2010 Nov; 9(11):2545-57. PubMed ID: 20823119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.
    Lin X; Ding J; Zhu L; Shi S; Jiang L; Zhao M; Zhang H
    Nephrol Dial Transplant; 2009 Nov; 24(11):3372-5. PubMed ID: 19531670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
    Wu J; Wang N; Wang J; Xie Y; Li Y; Liang T; Wang J; Yin Z; He K; Chen X
    Rapid Commun Mass Spectrom; 2010 Jul; 24(14):1971-8. PubMed ID: 20552702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy.
    Pirulli D; Crovella S; Ulivi S; Zadro C; Bertok S; Rendine S; Scolari F; Foramitti M; Ravani P; Roccatello D; Savoldi S; Cerullo G; Lanzilotta SG; Bisceglia L; Zelante L; Floege J; Alexopoulos E; Kirmizis D; Ghiggeri GM; Frascà G; Schena FP; Amoroso A;
    J Nephrol; 2009; 22(1):152-9. PubMed ID: 19229831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural analysis of O-glycopeptides employing negative- and positive-ion multi-stage mass spectra obtained by collision-induced and electron-capture dissociations in linear ion trap time-of-flight mass spectrometry.
    Deguchi K; Ito H; Baba T; Hirabayashi A; Nakagawa H; Fumoto M; Hinou H; Nishimura S
    Rapid Commun Mass Spectrom; 2007; 21(5):691-8. PubMed ID: 17279605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease.
    Hui GK; Wright DW; Vennard OL; Rayner LE; Pang M; Yeo SC; Gor J; Molyneux K; Barratt J; Perkins SJ
    Biochem J; 2015 Oct; 471(2):167-85. PubMed ID: 26268558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
    Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.
    Lehoux S; Mi R; Aryal RP; Wang Y; Schjoldager KT; Clausen H; van Die I; Han Y; Chapman AB; Cummings RD; Ju T
    Mol Cell Proteomics; 2014 Nov; 13(11):3097-113. PubMed ID: 25071157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
    Allen AC; Bailey EM; Barratt J; Buck KS; Feehally J
    J Am Soc Nephrol; 1999 Aug; 10(8):1763-71. PubMed ID: 10446944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.
    van den Wall Bake AW; Beyer WE; Evers-Schouten JH; Hermans J; Daha MR; Masurel N; van Es LA
    J Clin Invest; 1989 Oct; 84(4):1070-5. PubMed ID: 2794045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
    PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
    Julian BA; Wittke S; Novak J; Good DM; Coon JJ; Kellmann M; Zürbig P; Schiffer E; Haubitz M; Moldoveanu Z; Calcatera SM; Wyatt RJ; Sýkora J; Sládková E; Hes O; Mischak H; McGuire BM
    Electrophoresis; 2007 Dec; 28(23):4469-83. PubMed ID: 18004714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
    Horie A; Hiki Y; Odani H; Yasuda Y; Takahashi M; Kato M; Iwase H; Kobayashi Y; Nakashima I; Maeda K
    Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
    Park MR; Wang EH; Jin DC; Cha JH; Lee KH; Yang CW; Kang CS; Choi YJ
    Proteomics; 2006 Feb; 6(3):1066-76. PubMed ID: 16372274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
    Tomana M; Matousovic K; Julian BA; Radl J; Konecny K; Mestecky J
    Kidney Int; 1997 Aug; 52(2):509-16. PubMed ID: 9264010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
    Berthoux F; Suzuki H; Thibaudin L; Yanagawa H; Maillard N; Mariat C; Tomino Y; Julian BA; Novak J
    J Am Soc Nephrol; 2012 Sep; 23(9):1579-87. PubMed ID: 22904352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.